Kala Bio KALA
NASDAQ KALA
$0.56 +0.02 (+3.50%)
At close: Sep 9, 2026 · 4:00 PM EDT

Kala Bio (KALA) Accounts Payables (2016 - 2026)

Kala Bio's (KALA) quarterly Accounts Payables came in at $1.1 million in Q2 2026, up 73.56% year-over-year from $658000.0 in Q2 2025, and up 9.39% quarter-over-quarter from $1.0 million in Q1 2026.

Analysis

Kala Bio (KALA) Accounts Payables (2016 - 2026) Analysis & Trends

Kala Bio has disclosed Accounts Payables across 11 years of filings, most recently posting $1.1 million for Q2 2026.

  • In Q2 2026, Accounts Payables rose 73.56% year-over-year to $1.1 million; the TTM figure through Jun 2026 stood at $1.1 million (up 73.56% YoY), while the FY2025 annual figure was $986000.0, up 57.01% from the prior year.
  • Accounts Payables came in at $1.1 million for Q2 2026 at Kala Bio, up from $1.0 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $10.5 million in Q2 2022 to a low of $628000.0 in Q4 2024.
  • Average Accounts Payables over 5 years is $2.2 million, with a median of $925000.0 recorded in 2023.
  • Year-over-year, Accounts Payables surged 270.68% in 2022 and slumped 92.79% in 2023.
  • Over 5 years, Accounts Payables stood at $2.8 million in 2022, then slumped by 67.55% to $919000.0 in 2023, then plunged by 31.66% to $628000.0 in 2024, then soared by 57.01% to $986000.0 in 2025, then gained by 15.82% to $1.1 million in 2026.
  • Per Business Quant data, the three most recent Accounts Payables figures were $1.1 million in Q2 2026, $1.0 million in Q1 2026, and $986000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.52 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 108.02 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 403.90 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 428.93 Mn
10 Kala Bio 7.80 Mn 7.80 Mn - 1.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.14 Mn
Mar 31, 2026 1.04 Mn
Dec 31, 2025 986,000.00
Sep 30, 2025 917,000.00
Jun 30, 2025 658,000.00
Mar 31, 2025 931,000.00
Dec 31, 2024 628,000.00
Sep 30, 2024 711,000.00
Jun 30, 2024 665,000.00
Mar 31, 2024 732,000.00
Dec 31, 2023 919,000.00
Sep 30, 2023 787,000.00
Jun 30, 2023 760,000.00
Mar 31, 2023 997,000.00
Dec 31, 2022 2.83 Mn
Sep 30, 2022 7.35 Mn
Jun 30, 2022 10.54 Mn
Mar 31, 2022 6.22 Mn
Dec 31, 2021 4.90 Mn
Sep 30, 2021 5.85 Mn